Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

Clinical trial NCT04502966 · COMPLETED

Trial details

NCT number: NCT04502966
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis Grass Pollen Allergy

Start date: 2020-11-05
Primary completion: 2025-02-20
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.